CHRE Review Gives Society The Thumbs-Up

Main Category: Pharma Industry / Biotech Industry
Article Date: 02 Sep 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:4 stars

4 (1 votes)


The Royal Pharmaceutical Society of Great Britain has received a positive performance review from the Council for Healthcare Regulatory Excellence (CHRE), the health professions' watchdog. The independent report, Helping regulation to improve, showed that the Society successfully met the required level of performance in its regulatory duties during the 2007 / 2008 period.

Published on 29 August, the CHRE reports on the performance of all nine health professions regulators in the UK - looking at how each regulator functions and measuring their performance against agreed standards.

Wendy Harris, the Society's Deputy Registrar & Director of Regulation, said:

"The Society's regulatory team should be congratulated on such a positive report. The Society has been working through a difficult period of structural change but has committed to a 'business as usual' approach and maintained efficient and effective high standards. There is still a lot to do, and over the next year we will continue to maintain these high standards. We will also be looking at raising the profile of the Register, and introducing an updated IT-based case management system in fitness to practise in order to meet CHRE priorities for 2009."

The CHRE Performance Review for 2007 / 2008 is available in full from the CHRE website, http://www.chre.org.uk.

The Council for Healthcare Regulatory Excellence (CHRE)

CHRE is an independent statutory body covering all of the United Kingdom. It is accountable to the Westminster parliament. It was established by parliament in 2003 to ensure consistency and good practice in healthcare regulation.

The CHRE's primary purpose is to promote the health, safety and wellbeing of patients and the public. It scrutinises and oversees the health professions regulators, works with them to identify and promote good practice in regulation, carries out research, develops policy and gives advice.

The CHRE governs the following nine UK regulatory bodies:

- General Medical Council (GMC) - Nursing and Midwifery Council (NMC) - Health Professions Council (HPC) - General Dental Council (GDC) - General Optical Council (GOC) - General Chiropractic Council (GCC) - General Osteopathic Council (GOsC) - Royal Pharmaceutical Society of Great Britain (RPSGB) - Pharmaceutical Society of Northern Ireland (PSNI)

Council for Healthcare Regulatory Excellence

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Royal Pharmaceutical Society of Great Britain. "CHRE Review Gives Society The Thumbs-Up." Medical News Today. MediLexicon, Intl., 2 Sep. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/120003.php>

APA
Royal Pharmaceutical Society of Great Britain. (2008, September 2). "CHRE Review Gives Society The Thumbs-Up." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/120003.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »